Stock & Company Details
Foghorn Therapeutics Inc $FHTX
Price:
N/A
N/A
59M
$118M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.03
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FHTX technical indicators
Latest Foghorn Therapeutics Inc (FHTX) indicator readings as of 2026-10-09.
FHTX's 14-day RSI is 16.0, in oversold territory. At $2.00 it is trading 59.8% below its 200-day moving average of $4.97, and below its 50-day average of $4.82. Price sits near the lower Bollinger Band ($1.49 to $5.11). ADX reads 54.2, indicating a trending market.
Overview
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
Finance Bot
Ask your questions
Start by typing a question below.
